Patent holdings for IPC class C40B 40/02

Total number of patents in this class: 608

10-year publication summary

14
25
25
54
52
38
28
22
37
15
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc.
286
39
The Regents of the University of California
20087
17
Massachusetts Institute of Technology
10110
8
President and Fellows of Harvard College
5998
8
Yale University
2409
8
Genentech, Inc.
4001
7
Adimab, LLC
145
7
The Governing Council of The University of Toronto,
1484
7
DuPont US Holding, LLC
97
7
The Board of Trustees of the Leland Stanford Junior University
6462
6
Affinity Biosciences Pty Ltd
10
6
National Research Council of Canada
1547
6
The University of British Columbia
1509
6
48Hour Discovery Inc.
9
6
Takeda Pharmaceutical Company Limited
2706
5
Adaptimmune Limited
182
5
CytomX Therapeutics, Inc.
223
5
The Governors of the University of Alberta
873
5
Immunocore Limited
217
5
Nantbio, Inc.
140
5
Other owners 440